The mTOR inhibitor rapamycin (rap) is active against lymphoid leukemia (ALL) in vitro, treats advanced disease in a mouse model, and is antagonized by interleukin-7 (IL-7)
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- April 1, 2003
has subject area
- 1114 Paediatrics and Reproductive Medicine (FoR)
- 1117 Public Health and Health Services (FoR)
- Pediatrics (Science Metrix)
published in
- Pediatric Research Journal